Article Details

Gilead's Veklury receives NICE recommendation to treat COVID-19 in vulnerable adults and children

Retrieved on: 2024-04-12 17:30:49

Tags for this article:

Click the tags to see associated articles and topics

Gilead's Veklury receives NICE recommendation to treat COVID-19 in vulnerable adults and children. View article details on HISWAI: https://pmlive.com/pharma_news/gileads-veklury-recommended-by-nice-to-treat-covid-19-in-vulnerable-adults-and-children/

Excerpt

Gilead Sciences has announced that the National Institute for Health and Care Excellence (NICE) has recommended Veklury (remdesivir) to treat ...

Article found on: pmlive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up